Your browser doesn't support javascript.
loading
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B.
Yuen, Man-Fung; Berliba, Elina; Sukeepaisarnjaroen, Wattana; Ahn, Sang Hoon; Tanwandee, Tawesak; Lim, Young-Suk; Kim, Yoon Jun; Poovorawan, Kittiyod; Tangkijvanich, Pisit; Schwabe, Christian; Eley, Timothy; Brown, Joanne; Lee, Amy C H; Thi, Emily P; Paratala, Bhavna; Mani, Nagraj; Sofia, Michael J; Picchio, Gaston; Sims, Karen D; Gane, Edward J.
Afiliación
  • Yuen MF; Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
  • Berliba E; Arensia Exploratory Medicine, Chisinau, Moldova.
  • Sukeepaisarnjaroen W; Department of Medicine, Khon Kaen University, Srinagarind Hospital, Khon Kaen, Thailand.
  • Ahn SH; Department of Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
  • Tanwandee T; Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Lim YS; Department of Gastroenterology, Asan Medical Center, Seoul, Republic of Korea.
  • Kim YJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Poovorawan K; Faculty of Tropical Medicine, Hospital for Tropical Diseases, Mahidol University, Bangkok, Thailand.
  • Tangkijvanich P; Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University, Bangkok, Thailand.
  • Schwabe C; New Zealand Clinical Research, Auckland, New Zealand.
  • Eley T; Clinical Development, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Brown J; Clinical Development, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Lee ACH; Discovery, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Thi EP; Discovery, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Paratala B; Discovery, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Mani N; Discovery, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Sofia MJ; Discovery, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Picchio G; Clinical Development, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Sims KD; Clinical Development, Arbutus Biopharma, Warminster, Pennsylvania, USA.
  • Gane EJ; Department of Medicine, University of Auckland, Auckland, New Zealand.
Hepatol Commun ; 6(12): 3457-3472, 2022 12.
Article en En | MEDLINE | ID: mdl-36194181
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Hepatitis B Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Hepatol Commun Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Hepatitis B Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Hepatol Commun Año: 2022 Tipo del documento: Article País de afiliación: China